Guangdong VTR Bio-Tech Co., Ltd.

Shenzhen Stock Exchange 300381.SZ

Guangdong VTR Bio-Tech Co., Ltd. Shareholders' Equity for the year ending December 31, 2023: USD 368.26 M

Guangdong VTR Bio-Tech Co., Ltd. Shareholders' Equity is USD 368.26 M for the year ending December 31, 2023, a -6.08% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Guangdong VTR Bio-Tech Co., Ltd. Shareholders' Equity for the year ending December 31, 2022 was USD 392.11 M, a -10.79% change year over year.
  • Guangdong VTR Bio-Tech Co., Ltd. Shareholders' Equity for the year ending December 31, 2021 was USD 439.53 M, a -3.66% change year over year.
  • Guangdong VTR Bio-Tech Co., Ltd. Shareholders' Equity for the year ending December 31, 2020 was USD 456.24 M, a 28.88% change year over year.
  • Guangdong VTR Bio-Tech Co., Ltd. Shareholders' Equity for the year ending December 31, 2019 was USD 354.00 M, a 13.66% change year over year.
Key data
Date Shareholders' Equity Minority Interest Total Equity Total Stockholders Equity and Liabilities
Market news
SV Wall Street
Shenzhen Stock Exchange: 300381.SZ

Guangdong VTR Bio-Tech Co., Ltd.

CEO Mr. Derong Zhou
IPO Date Jan. 28, 2014
Location China
Headquarters No. 8 Pingbei Road 1
Employees 1,119
Sector Healthcare
Industries
Biotechnology Agriculture Biofuel Fertilizers Personal Care Pet Food Pharmaceuticals Plastics
Description

Guangdong VTR Bio-Tech Co., Ltd., focuses on research, development, and industrial application of bio-medicine, bio-agriculture, and animal husbandry. The company provides feed enzymes, functional feed additives, and industrial enzyme products. The company sells its products in approximately 60 countries and regions. Guangdong VTR Bio-Tech Co., Ltd. was founded in 1991 and is headquartered in Zhuhai, China.

StockViz Staff

February 3, 2025

Any question? Send us an email